stella
beta
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer — Stella
Recruiting
Back to Metastatic Pancreatic Cancer trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(6 sites)
United States
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California
Boca Raton Regional Hospital, Lynn Cancer Institute, Boca Raton, Florida
Williamette Valley Cancer Institute and Research Center, Eugene, Oregon
AHN Cancer Institute - Allegheny General Hospital, Pittsburgh, Pennsylvania
Prisma Health - Upstate, Greenville, South Carolina
Show all 6 locations
View full record on ClinicalTrials.gov